Expanding Buprenorphine Use in Primary Care: Changing the Culture

The Permanente Journal

article

Abraham Leiser¹  Maria Robles² 

[1] School of Medicine, Indiana University;Department of Medicine, School of Medicine, Indiana University

关键词: addiction;    buprenorphine;    primary care;    opioid agonist therapy;    opioid use disorder;    substance use disorder;   

DOI  :  10.7812/TPP/21.203

学科分类：医学（综合）

来源: Permanente Medical Group

【 摘 要 】

Despite concerted media and public health attention, opioid overdose remains the leading cause of accidental death among young adults in the United States.1 Evidence shows that the most effective treatment for opioid use disorder (OUD) is opioid agonist treatment (OAT).2 OAT has been shown to be twice as effective at preventing relapse as behavioral treatment without OAT.3 Despite these compelling results, the gap between maximum OAT capacity and treatment need is on the order of a million individuals in the United States.4 Buprenorphine has limited abuse and overdose potential because its partial agonism it does not reach the same euphoric effects compared to full opioid agonists, and combining it with naloxone voids any effect if snorted or used intravenously. These characteristics make it an excellent choice in the outpatient setting. We describe the successful initiation of a primary care based OAT program at our academic, safety net medical center in a Midwest city. We have one hospital that is associated with eight federally qualified health centers.

【 授权许可】

Unknown